Fig. 5From: A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathwayIn vivo mechanism of 2b. a, b Images and statistical analysis of apoptosis in tumor tissue determined by TUNEL. c, d Image and statistical analysis of CD31 expression in tumor tissue. e, f Image and statistical analysis of capillary tube formation. h, i Degradation of ruthenium over time in plasma, blood cells and organs after administration of a single 2b dose of 5Â mg/kgBack to article page